PofoliaShared via Pofolia

Journal of Clinical Monitoring and Computing· 2026Q2

Contact heat evoked potentials as a measure of the analgesic component of anesthesia – a patient study

Robert Zanner, G. Untergehrer, Denis Jordan, Matthias Kreuzer et al.

Short summary

Contact heat evoked potentials (CHEPs) are unsuitable for directly measuring the analgesic component of general anesthesia, as CHEP amplitudes did not correlate with patient-reported pain (VAS) and were undetectable after propofol-induced loss of responsiveness.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract To assess the applicability of contact heat evoked potentials (CHEPs) as a direct measure of analgesia, we analyzed the following endpoints. (1) Correlation between remifentanil-induced changes in VAS and CHEP amplitudes. (2) Correlation between CHEP amplitude reduction and remifentanil infusion rate. Furthermore, we investigated the sedative effects of remifentanil and the effect of propofol-induced loss of responsiveness (PI-LOR) on CHEPs. After determination of the individual pain threshold (visual analog scale (VAS) of 10), 120 adult ASA physical status I or II patients randomly received remifentanil in one of four predefined infusion rates (0.05, 0.1, 0.2, or 0.4 $$\upmu$$ g/kg/min). After equilibration, a heat stimulus 20% above the individual pain threshold was applied to the volar forearm. Eventually, propofol was infused until LOR, and the heat stimulus was applied again. CHEPs, VAS, and the Observer’s Assessment of Alertness/Sedation (OAA/S) scale, as well as middle latency auditory evoked potentials (MLAEPs), were assessed. A total of 119 patients were included in the analysis. CHEP amplitudes could not be detected for all patients at all times. Remifentanil dosage and VAS showed a strong inverse correlation (r=-0.46; p<0.001). We also detected a correlation between remifentanil dosage and CHEP amplitudes (r=0.29; p=0.003) but not between VAS and CHEPs (r=-0.17; p=0.868). Both the OAA/S score and MLAEPs indicated a correlation between remifentanil dosage and degree of sedation. After PI-LOR, CHEPs were no longer detectable. The exact mechanism for the detected CHEP reduction remains to be determined. CHEPs monitoring appears unsuitable for direct assessment of the analgesic component of general anesthesia. Trial registration: German Clinical Trials Register ID DRKS00003300, Oct 24, 2011.

The authors' abstract, as published at the source. Journal of Clinical Monitoring and Computing, 2026 · DOI ↗

TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Sign in on the web to open

Field: Anesthesiology and Pain Medicine

Anesthesiology and Pain MedicineMedicine